DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

University of Aarhus

Status and phase: Completed; Phase 2

Conditions: Neoplasms, Second Primary; Head and Neck Neoplasms; Recurrence

Treatments: Procedure: Radiotherapy

Study type: Interventional

Funder types: Other; NETWORK

Identifiers

NCT00400426

DAHANCA 20

Details and patient eligibility

About

Palliative radiotherapy for head and neck cancer is widely used but the effect and side effects are largely unknown. We will study the effect of short hypofractionated palliative radiotherapy (20 Gy in 4 fractions) on symptom intensity and -frequency as weel as side effects

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Incurable primary or second primary head and neck cancer
• Speaks and reads Danish
• Capable of filling out questionnaires for at leas two months after radiotherapy
• Age>=18 years
• Expected survival> 3months

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)